Loading clinical trials...
Loading clinical trials...
An Open-Label Randomized Pilot Study of Safety and Preliminary Efficacy of TG100801 in Patients With Choroidal Neovascularization Due to Age-Related Macular Degeneration
Conditions
Interventions
TG100801
Locations
8
United States
Retina Centers, PC
Tucson, Arizona, United States
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
Center for Retina and Macular Disease
Winter Haven, Florida, United States
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Vitreous-Retina-Macula Consultants of New York
New York, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Start Date
July 1, 2007
Primary Completion Date
March 1, 2008
Completion Date
March 1, 2008
Last Updated
March 29, 2010
NCT05913063
NCT07446582
NCT06779773
NCT06990269
NCT06970665
NCT07160179
Lead Sponsor
TargeGen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions